Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of COV.V is 2.9 and suggests 56% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell